Biostealth Technology​

Enhances the biocompatibility and extends the lifespan of medical devices and life support equipment

BCI’s biostealth technology platform is designed to enhance medical device biocompatibility and longevity by minimizing adverse biological reactions.

Protego®, Facta®, Firmo®, and D-Fendor® use plant-based molecules that form stable bonds with device materials, supporting long-term biological integration across a broad range of medical applications.

These patented technologies are designed to inhibit the key drivers of device failure, including immune-mediated responses, thrombosis, infection, inflammation, and calcification.

Plant-Based Technology

For medical devices made with polymers, metals, and ceramics
For conventionally cross-linked biologic medical devices
For biologic medical devices, replacing current cross-linking methods and fixatives
For dental implants, supporting osseointegration and peri-implant mucosal tissue sealing

One Platform. Multiple Solutions.

Targeting the key biological causes of medical device failure

By limiting the biological mechanisms that contribute to device degeneration, BCI’s technologies are engineered to preserve device integrity and maintain functionality after implantation.
 
Longer-lasting devices can help reduce complications, limit repeat procedures, and ease the overall burden of care for both patients and healthcare systems.

Key Benefits

Significant patient and healthcare upside plus access to new patient populations

Compatible with new generation and currently approved medical devices

Extended device lifespan while maintaining intended functionality

Potential to expand treatment options for previously ineligible patient populations

Improved patient quality of life and long-term clinical management

Potential to reduce the burden on healthcare systems

Designed for scalable integration into medical device manufacturing

BCI is committed to developing safe, durable, and responsible solutions for unmet clinical needs.

Our technologies continue to undergo extensive testing and independent evaluation as we move toward regulatory approval.
 
BCI partners with internationally recognized scientists, medical experts, researchers, and leading manufacturers to validate the efficacy and safety of our technologies.